It is widely known that HIV and ARV drugs trigger mitochondrial impairment in adults. However, their effects in perinatally-infected children have been poorly explored. For this reason, the main hypothesis of the present Thesis was to demonstrate that mitochondrial abnormalities are present in HIV-infected pediatric patients treated with ARV. It is expected to find mitochondrial alterations in asymptomatic perinatally HIV-infected children. This mitochondrial lesion, manifested in a depletion of the mitochondrial genome, would lead to a reduction of the mitochondrial protein synthesis or to a mitochondrial dysfunction and, as a last resort, compromising the cellular viability. However, it is also possible that the presence of homeostatic mechanisms in mitochondria entails a proper function of some complexes, even in the presence of mitochondrial genome depletion. Rather than a localized mitochondrial alteration in a specific enzymatic activity, it is possible that HIV and ARV cause a diffuse damage in the organelle which may be observed in a general assessment of the respiratory chain. In case of a mitochondrial alteration, either in asymptomatic or symptomatic patients, it would be expected a more evident presentation of mitochondrial toxicity in case of the latter. If our hypothesis of an evidence of mitochondrial toxicity derived from HIV and ARV in children is confirmed, we believe that, once the detrimental agent is withdrawn, a recover of the mitochondrial affectation is possible. Mitochondrial impairment may change depending on the type of HAART regimen, leading us to use mitochondrial parameters as a biomarker or a trail to find the best therapeutic options in the choice of different HAART schedules. In this context, the intensity of mitochondrial impairment over time would be higher in children receiving first generation NRTI which, in turn, have been demonstrated to present a higher mitochondrial toxicity in vitro, than those under second generation NRTI. In order to study and test our hypothesis, the main objectives of the present Thesis are: A) General Objective To test if HIV and ARV mechanisms of mitochondrial toxicity found in adults are present in perinatally HIV-infected children. B) Specific Objectives - Objective 1: To elucidate whether ARV treatment or HIV infection were exerting a mitochondrial toxic effect in asymptomatic perinatally HIV-infected pediatric patients receiving HAART. - Objective 2: To investigate if hypothetic alterations in the mitochondrial genome of asymptomatic HIV-infected children receiving ARV are downstream reflected at transcriptional, translational and functional levels. In case of mitochondrial dysfunction was present, to test whether MRC alterations are focalized or diffuse. - Objective 3: To determine mitochondrial status in lipodystrophic HIV-children and compare them to a group of asymptomatic children and to a group of uninfected controls. - Objective 4: To evaluate whether a 12-month interruption of ARV is able to improve or revert these hypothetic mitochondrial alterations at molecular and/or clinical level. - Objective 5: To compare mitochondrial toxicity derived from different HAART schedules in a longitudinal 2-year follow-up assessment of immunovirological and mitochondrial status under first or second generation NRTI. To elucidate whether those NRTI demonstrated to present high mitochondrial toxicity in vitro present a major toxicity in vivo as well.

Las etapas iniciales de la infección por VIH se caracterizan por elevados niveles de ARN viral, que pueden estar contribuyendo significativamente a la transmisión del virus y al mantenimiento de la epidemia. Existe poca información sobre estas etapas precoces de la infección en zonas de África donde predomina el subtipo C del VIH. Este trabajo ha caracterizado la epidemiología y los parámetros inmuno-virológicos de las fases iniciales de la infección por VIH en una zona del sur de Mozambique La primera parte de este trabajo se enfocó en la identificación de infecciones agudas (AHI) en pacientes ambulatorios de una zona semi-rural del sur de Mozambique. En esta zona endémica de malaria, la población está habituada a acudir al hospital tras sentir síntomas febriles característicos de la malaria, pero también del síndrome retroviral agudo del VIH. Esta situación, presente en muchos países del sur de África, presenta una oportunidad de dirigir una búsqueda de casos de AHI hacia pacientes con síndrome febril. Usando esta estrategia, se describió una elevada prevalencia de AHI (3.3%) en los pacientes ambulatorios con síndrome febril. Estos pacientes mostraron elevados niveles de carga viral (CV) y de activación de las células T-CD8. En la segunda parte de este trabajo, se caracterizó la infección reciente por VIH, definida como los primeros 12 meses desde la infección. Se encontró una baja prevalencia de infecciones recientes por VIH (11.58%) en personas que acuden voluntariamente al centro de asesoramiento para VIH del hospital. Un grupo de pacientes identificados con infección reciente por VIH mostraron, como en el caso de los AHI, elevados niveles de carga viral por encima de 105 copias/ml de plasma que fueron mantenidos durante los 10 meses de seguimiento. Estos pacientes con elevados niveles de CV representarían un mayor riesgo de transmisión del VIH, señalando la importancia en la identificación de infecciones agudas y recientes para las estrategias de prevención del VIH. Los resultados de esta tesis reúnen información sobre la epidemiología de las fases iniciales de la infección por VIH en una zona de elevada prevalencia donde no había datos previos. Estos resultados contribuyen a la caracterización de las fases tempranas de la infección por VIH con la perspectiva de llevar a cabo intervenciones en las fases iniciales para mejorar el pronóstico del paciente y disminuir el riesgo de transmisión. Además apoyan la necesidad de más desarrollo de pruebas de diagnóstico rápido para la detección de las fases tempranas en condiciones locales.

Urinary tract infection (UTIs) is an extremely common disease. Proteus mirabilis is a common cause of UTI in individuals with functional or structural abnormalities or with long-term catheterization, it forms bladder and kidney stones as a consequence of urease-mediated urea hydrolysis. Known virulence factors, besides urease, are flagella, fimbriae, outer membrane proteins, hemolysins, amino acid deaminase, protease, capsule and lipopolysaccharide (LPS). Study of LPS core is particularly relevant for several reasons: it is a conserved region, although it is increasingly clear that there is some variability at the genus or groups of similar genera, its chemical structure modulates the endotoxic activity of lipid A, alteration of the LPS core, which generates less virulent bacteria, encourages the search of substances that interfere with the biosynthesis of this region, and conserved regions of the core LPS could be useful as antigens in preventing diseases caused by pathogens that contain these conserved regions. The specific aims of this project have been to identify and functionally characterize genes involved in core LPS biosynthesis in P. mirabilis, to elucidate the mechanism of incorporation of galactosamine (GalN) to the core LPS, to identify genes coding for phosphoethanolamine (PEtN) modifications, and to characterize and to study the biological effects of the gene encoding the PEtN transferase involved in the modification of the second heptose residue (L,D-HepII). We found that P. mirabilis has most of the genes for the biosynthesis of LPS core grouped in the waa cluster in the chromosome. Despite this, additional genes required for core LPS biosynthesis are found outside the waa cluster. The pentasaccharide of the inner core, shared by all Enterobacteriaceae, is biosynthesized in P. mirabilis, by the sequential activity of a bifunctional transferase (WaaA) and three heptosyltransferases (WaaC, WaaF, and WaaQ). These enzymes are transcribed from genes located inside the waa cluster, and are conserved in P. mirabilis strains analyzed; for more, they show a high identity and similarity level to homologues proteins of Escherichia coli, Klebsiella penumoniae and Serratia marcescens. The waaL gene, coding for the O-antigen polymerase ligase, is found adjacent to the classic waa cluster. Downstream this gene, four genes encoding enzymes belonging to the 4 (walM, walN, and WalR), and 9 (walO) glycosyltransferase family were found. Even if members of these families were related to LPS core biosynthesis in several Gram-negative bacteria, in P. mirabilis they do not appear to be involved in the biosynthesis of the reported core LPS structures. The presence of the disaccharide hexosamine (HexN)-1,4-galacturonic acid (GalA) is a feature of P. mirabilis LPS outer core. Depending on the nature of the HexN outer core residue, two different homologues for N-acetyl-hexosamine transferases are present in the waa cluster: wabH or wabP. Altought the incorporation of glucosamine into LPS core requires an acetylglucosaminyltransferase (WabH) and a deacetilase (WabN), the incorporation of GalN requires three enzymes: an acetylgalactosaminyltransferase (WabP), a deacetilase (WabN) and an epimerase (gne). An amplification test with specific primers for this two different homologues can be used to predict the HexN nature in P. mirabilis LPS cores. The strain-specific genes wamB and wamC code for a galactosyltransferase and a heptosyltransferase respectively in strain R110 of P. mirabilis. The enzyme encoded by gene wamD is a N-acetylglucosaminyltransferase, and it is found in strain 51/57 of P. mirabilis. WamA, coded by wamA gene in the waa cluster of strains R110, 50/57, TG83 and HI4320, is a heptosyltransferase responsible for the incorporation of a quarter residue of heptose (Hep), in DD configuration, to the GalA II of the outer core. In P. mirabilis strain 51/57, a gene coding a protein of the Mig-14 family was identified inside the waa cluster, this localization appears to be an exception in the Enterobacteriaceae family. Inspection of the whole genome of P. mirabilis HI4320 did not allow the identification of a mig-14 similar gene. There are three putative PEtN transferases in the genome of P. mirabilis: PMI3040, PMI3576, and PMI3104. The gene identified as eptC (PMI3104) transfers the moiety of PEtN to the O-6 position of L,D-Hep II (HepII6PEtN). The absence of the positive charge due to PEtN residue doesn't affect the bacterial growth kinetics in lab conditions in rich or defined media, but causes a moderate destabilization of the outer-membrane. Despite the lack of the PEtN residue on the Hep II in P. mirabilis LPS core, has no statistically effects during urinary tract infection assays in mouse model, the absence of this modification causes an increase sensitivity to complement in non-immune human sera. / P. mirabilis no es una causa frecuente de infecciones urinarias en el huésped normal, más bien infecta el tracto urinario con alteraciones funcionales o anatómicas, o instrumentación crónica como el cateterismo. P. mirabilis está a menudo asociado con cálculos urinarios e incrustaciones de los catéteres y es, particularmente importante, en pacientes con cateterización prolongada. Las infecciones del tracto urinario asociadas a cateterización son mundialmente reconocidas como la causa más común de infección asociada a tratamientos en ambiente hospitalario. El LPS es un factor de virulencia importante en bacterias Gram negativas patógenas. También conocido como endotoxina, es una molécula glicolipídica que constituye la estructura mayoritaria de la cara externa de la membrana externa (OM). En Proteus mirabilis la mayoría de los genes responsables de la biosíntesis de núcleo de LPS están localizados en el cromosoma, en el agrupamiento génico waa. A pesar de esto, algunos genes adicionales, necesarios para la biosíntesis del núcleo de LPS, se encuentran ubicados fuera del agrupamiento génico waa. El pentasacárido del núcleo interno, común a todas las Enterobacteriáceae, se biosintetiza en P. mirabilis, por la actividad secuencial de una transferasa bifunciona (WaaA) y tres heptosiltransferasas (WaaC, WaaF, y WaaQ). La presencia del disacárido HexN‐1,4‐GalA es característica del núcleo externo de LPS en P. mirabilis. Dependiendo de la naturaleza del residuo de HexN, se encuentran, en el agrupamiento génico waa, dos HexNAc transferasas diferentes: wabH o wabP. El gen eptC (PMI3104) codifica para la enzima que transfiere el residuo de fosfoetanolamina a la posición O-6 de la L,D-Hep II (HepII6PEtN), en el núcleo de LPS de P. mirabilis. La ausencia de la carga positiva del residuo de fosfoetanolamina no afecta a la cinética de crecimiento de las bacterias en condiciones standard de laboratorio sea en medios ricos o definidos. La ausencia del residuo fosfoetanolamina provoca una desestabilización moderada de la membrana externa que se traduce en una disminución de la MIC para SDS.

Treatment failure in community-acquired pneumonia (CAP) is the failure to normalize the clinical features (eg, fever, cough, sputum production), or nonresolving image in chest radiograph, despite antimicrobial therapy. The incidence of treatment failure in CAP has not been clearly established; according to several studies it ranges between 6% and 15%. The rate of mortality increases significantly, especially in those patients with severe CAP. It is important to be able to identify what patients are at risk for progressive or treatment failure pneumonia that may make them candidates for a more careful monitoring. This doctoral thesis has been structured following the guidelines of the rules for submission of doctoral theses as a compendium of publications, adopted by the Council, Department of Medicine, University of Barcelona. The studies are part of this thesis belong to the same line of research, validated the current guidelines of pneumonia-community acquired and hospital acquired. The results of the studies have provided relevant and innovative in this field and were collected in 2 original articles published in international journals with a widespread global impact factor of 16,37 points.

Introdução: Em pacientes críticos, como os grandes queimados, todos os parâmetros farmacocinéticos (absorção, distribuição, metabolismo e excreção) de muitas classes de drogas, incluindo antimicrobianos, estão alterados. Devido à forte associação entre a terapia antimicrobiana adequada em pacientes com queimaduras e mortalidade, intervenções como o monitoramento terapêutico de drogas podem ser uteis para otimizar a concentração sérica desses agentes em diferentes estágios do estado hiperdinâmico. Portanto, é possível melhorar desfecho clínico e sobrevivência além de reduzir o desenvolvimento de resistência. O objetivo deste estudo foi analisar o impacto em mortalidade de uma estratégia de ajuste de dose de acordo com o monitoramento terapêutico e modelagem farmacocinética/farmacodinâmica em pacientes de uma Unidade de Terapia Intensiva (UTI) para Queimados. Métodos: Um estudo comparativo, retrospectivo, foi conduzido entre pacientes admitidos com pneumonia, infecção em queimadura, infecção de corrente sanguínea e/ou infecção do trato urinário associados à assistência à saúde em uma UTI para Queimados do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP). Estes pacientes foram divididos em dois grupos: aqueles admitidos de maio de 2005 a outubro de 2008 que receberam antibioticoterapia em regime de dose convencional proposto pelo Grupo de Controle de Infecção Hospitalar do HC-FMUSP e aqueles admitidos de novembro de 2008 a junho de 2011 que receberam terapia antimicrobiana com dose ajustada de acordo com o monitoramento plasmático e modelagem farmacocinética. Características gerais dos dois grupos foram analisadas e desfechos clínicos (melhora dos sinais e sintomas da infecção), mortalidade em 14 dias e mortalidade hospitalar foram comparados. Resultados: 63 pacientes admitidos na UTI de Queimados apresentaram os critérios de inclusão para o grupo de tratamento convencional e 77 para o grupo de tratamento monitorado. Comparando dois grupos homogêneos em suas características gerais, houve diferenças quanto ao número de desbridamentos realizados e história de alcoolismo e uso de drogas ilícitas, mais frequentes no grupo de tratamento monitorado. Melhora clínica ocorreu em 56% dos pacientes sob regime monitorado e a mortalidade hospitalar foi similar entre os grupos. Pertencer a um dos grupos de tratamento não afetou o prognóstico. Na análise multivariada final, variáveis significativamente associadas com mortalidade hospitalar foram superfície corporal queimada maior que 30%, idade mais avançada e sexo masculino. Conclusão: Nosso estudo demonstrou que a estratégia de monitoramento terapêutico de antimicrobianos não alterou prognóstico de pacientes queimados. Acreditamos que são necessários mais estudos para embasar esta estratégia / Introduction: In critical patients, such as burn patients, pharmacokinetic parameters (absorption, distribution, metabolism and excretion) of many classes of drugs, including antibiotics, are altered. The aim of this study was to compare two groups of burned patients under treatment for healthcare associated infections with and without therapeutic drug monitoring (TDM) based on PK/PD modeling. Methods: A comparative study was conducted with patients with healthcare-associated pneumonia, burn infection, bloodstream infection and urinary tract infection in the Burn Intensive Care Unit (ICU) of a tertiary-care hospital. These patients were divided into two groups: 1) those admitted from May 2005 to October 2008 who received conventional antimicrobial dose regimen; and 2) those admitted from November 2008 to June, 2011 who received antibiotics with doses adjusted according to plasma monitoring and pharmacokinetics modeling. General characteristics of the groups were analyzed and clinical outcomes, 14-day and in-hospital mortality. Results: 63 patients formed the conventional treatment group and 77 the monitored treatment group. The groups were very homogeneous. Improvement occurred in 56% of the patients under monitored treatment and the in-hospital mortality was similar between groups. In the final multivariate models, variables significantly associated with in-hospital mortality were total burn surface area (TBSA) > 30%, older age and male sex. Treatment group did not affect the prognosis. Conclusions: TDM for antimicrobial treatment did not alter the prognosis of burn patients. More trials are needed to support the use of TDM to optimize treatment in burn patients